semaglutide westchase Weight Loss Clinics in | Weight Loss Specialist in Westchase Padgett Medical Center | Medical

FLOW investigators studied the effects of semaglutide (Ozempic, 1 mg/week) versus placebo in patients with type 2 diabetes and chronic kidney disease (low GFR and urine microalbumin)

This product is made in a cGMP-certified facility

NAD+ supports cellular repair, mitochondrial efficiency, and energy production, while Tirzepatide improves appetite control and insulin signaling

The interaction between GLP-1RAs and gut microbiota introduces a novel pharmaco-gut interface, emphasizing the role of microbial composition in drug response

Learn how to safely combine intermittent fasting with GLP-1 receptor agonists

PlexusDx explains what you need to know before combining supplements with GLP-1 therapy